Verve Therapeutics Inc. (NASDAQ: VERV) started the day on May 25, 2023, with a price decrease of -3.29% at $15.87. During the day, the stock rose to $16.82 and sunk to $15.57 before settling in for the price of $16.41 at the close. Taking a more long-term approach, VERV posted a 52-week range of $10.70-$43.00.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -17.50%. This publicly-traded company’s shares outstanding now amounts to $61.79 million, simultaneously with a float of $55.51 million. The organization now has a market capitalization sitting at $959.18 million. At the time of writing, stock’s 50-day Moving Average stood at $15.76, while the 200-day Moving Average is $24.23.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 204 workers. It has generated 9,515 per worker during the last fiscal year. Meanwhile, its income per employee was -771,505. The stock had 3.84 Receivables turnover and 0.00 Total Asset turnover. For the Profitability, stocks gross margin was -245.75, operating margin was -8536.17 and Pretax Margin of -8105.82.
Verve Therapeutics Inc. (VERV) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Verve Therapeutics Inc.’s current insider ownership accounts for 1.00%, in contrast to 105.10% institutional ownership. According to the most recent insider trade that took place on Dec 01, this organization’s CSO & CMO sold 865 shares at the rate of 22.95, making the entire transaction reach 19,852 in total value, affecting insider ownership by 6,629. Preceding that transaction, on Nov 29, Company’s Chief Financial Officer sold 554 for 22.10, making the whole transaction’s value amount to 12,243. This particular insider is now the holder of 2,186 in total.
Verve Therapeutics Inc. (VERV) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 3/30/2023, the organization reported -$0.84 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.78) by -$0.06. This company achieved a net margin of -8108.55 while generating a return on equity of -34.66. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.93 per share during the current fiscal year.
Verve Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -17.50% and is forecasted to reach -3.79 in the upcoming year.
Verve Therapeutics Inc. (NASDAQ: VERV) Trading Performance Indicators
Let’s observe the current performance indicators for Verve Therapeutics Inc. (VERV). It’s Quick Ratio in the last reported quarter now stands at 15.40. The Stock has managed to achieve an average true range (ATR) of 1.08. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 290.66.
In the same vein, VERV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.14, a figure that is expected to reach -0.91 in the next quarter, and analysts are predicting that it will be -3.79 at the market close of one year from today.
Technical Analysis of Verve Therapeutics Inc. (VERV)
If we take a close look at the recent performances of Verve Therapeutics Inc. (NASDAQ: VERV), its last 5-days Average volume was 0.6 million that shows plunge from its year to date volume of 0.7 million. During the previous 9 days, stock’s Stochastic %D was recorded 21.72% While, its Average True Range was 1.08.
Raw Stochastic average of Verve Therapeutics Inc. (VERV) in the period of the previous 100 days is set at 24.49%, which indicates a major rise in contrast to 10.24% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 60.02% that was lower than 64.72% volatility it exhibited in the past 100-days period.